News | April 25, 2024
Devyser receives IVDR approval for post-transplant monitoring software
Find out more
Devyser´s annual report 2023 has today been published on the company´s website. The report is...
Devyser has secured a CFTR NGS proposal with UNC Hospitals. The proposal with UNC Hospitals is...
Devyser Diagnostics AB announces today an article titled “Detection of donor-derived cell-free DNA...
“Devyser is able to report strong sales growth and record high gross margins for the fourth...
Devyser Genomic Laboratories, Devyser's US-based CLIA-certified laboratory, has signed its first...
Devyser has been awarded a tender for Devyser’s CFTR fragment analysis products, that are used for...
Devyser Diagnostics AB has entered an in vitro diagnostic development agreement with Illumina, Inc....
Devyser has been awarded a tender for Devyser’s CFTR fragment analysis products, that are used for...
Devyser has been awarded a tender for Devyser RHD, its product for non-invasive fetal RHD status in...